Hyundai Motor Co. exported four units of a hydrogen fuel cell system to Swiss-based GRZ Technologies Ltd. and an unidentified European startup, paving the way for further shipments of the energy solution.
GRZ Technologies Ltd., which specializes in energy storage in the form of hydrogen, and the European startup will manufacture portable power generators based on the 95-kilowatt hydrogen fuel cell systems.
A Hyundai spokesman noted that starting with the shipment to Europe, Hyundai aims to export more hydrogen fuel cell systems to other markets such as the US and China.
The shipment is in line with South Korea's plan to foster hydrogen fuel cell systems along with hydrogen fuel cell electric passenger and commercial vehicles as a key export item.
Hyundai Motor exported 1,790 units of the Nexo hydrogen passenger cars from 2018 through August this year, on top of the 8,908 units sold domestically.
In July, Hyundai Motor shipped 10 XCIENT Fuel Cell hydrogen trucks to Switzerland.
Hyundai plans to deliver 40 more XCIENT trucks to Switzerland by December as part of its long-term contract to export 1,600 XCIENTs to the country by 2025.
Under the group's 2018 plan, Hyundai Motor Group will invest 7.6 trillion won in hydrogen car-producing facilities and related R&D activities by 2030 to enable it to produce 500,000 hydrogen vehicles in 2030.


SK Hynix Shares Surge on Record $28.6 Billion Buyback
Moody’s Affirms NVIDIA Aa1 Rating as AI Data Center Guarantees Reach $105 Billion
Unitree Robotics Shares Soar Over 600% in Shanghai Market Debut
Toyota, Honda Shares Rise on Possible U.S.-Canada Auto Tariff Cut
Anthropic Eyes $10B-Plus Credit Line Ahead of Potential IPO
Moody’s Upgrades Vodafone Hybrid Debt Ratings to Baa3
CK Hutchison Seeks $1.5 Billion From Panama Over Canal Ports
Schott Pharma Stock Rises as Barclays Upgrades Rating on Growth Outlook
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars
Google to Move All Pixel Production Out of China by 2027
Sun Pharma Wins U.S. Appeal in Pfizer Lipitor Antitrust Case
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
Nordson Stock Rises as Q3 Earnings Beat Estimates, Outlook Raised
SEC Sues Former Tricolor Executives Over $1.9 Billion Investor Fraud Scheme
Samsung Eyes $72 Billion Shareholder Return Plan as AI Chip Boom Fuels Profits
Hermès Stock Downgraded by RBC as Luxury Growth Premium Narrows 



